Interpreting vedolizumab persistence: lessons from real-world trajectories in ulcerative colitis

Key Points

• Persistence of vedolizumab in ulcerative colitis impacts long-term clinical outcomes, enhancing treatment efficacy.
• Data from various healthcare settings highlights how treatment retention shapes patient management strategies.
• Observational analysis reveals trends in vedolizumab usage over time, assessing effectiveness and tolerability.
• Highlights the need for tailored treatment approaches based on individual persistence patterns in clinical settings.